Relationship Between Selective Cyclooxygenase-2 Inhibitors and Acute Myocardial Infarction in Older Adults

Circulation - United States
doi 10.1161/01.cir.0000127578.21885.3e
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial Infarction

Circulation
Cardiovascular MedicinePhysiologyCardiology
2006English

Relationship Between Edema and Wall Thickness in Acute Myocardial Infarction

Journal of Cardiovascular Magnetic Resonance
Nuclear MedicineRadiologyUltrasound TechnologyCardiologyFamily PracticeRadiologicalCardiovascular MedicineImaging
2010English

Impact of Hospitalization for Acute Myocardial Infarction on Adherence to Statins Among Older Adults

Circulation. Cardiovascular quality and outcomes
MedicineCardiovascular MedicineCardiology
2016English

Reduction in Cancer Risk by Selective and Nonselective Cyclooxygenase-2 (COX-2) Inhibitors

Journal of Experimental Pharmacology
Molecular MedicinePharmacology
2012English

Relationship Between Collateral Blood Flow and Microvascular Perfusion After Reperfused Acute Myocardial Infarction

Japanese Heart Journal
2003English

Relationship Between Myocardial Damage and C-Reactive Protein Levels Immediately After Onset of Acute Myocardial Infarction

Japanese Circulation Journal
2001English

Acute Pharmacological Treatment Given to Older Adults With Acute Myocardial Infarction: A Nationwide Emergency Department Study, 1992–2010

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Impact of Type 2 Diabetes Mellitus on Hospitalization Costs in Older Patients With Acute Myocardial Infarction

Clinical Interventions in Aging
MedicineGerontologyGeriatrics
2014English

Acute Myocardial Infarction

British Medical Journal
Medicine
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy